The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

被引：0
|
作者：
Kongju Wu
Ming Yi
Shuang Qin
Qian Chu
Xinhua Zheng
Kongming Wu
机构：
[1] Medical School of Pingdingshan University,Department of Clinical Medicine
[2] Huazhong University of Science and Technology,Department of Oncology, Tongji Hospital of Tongji Medical College
来源：
Experimental Hematology & Oncology | / 8卷
关键词：
Immunotherapy; PD-1; PD-L1; CTLA-4; Immune checkpoint inhibitor; Combination therapy; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Combination of CTLA-4 and PD-1 blockers for treatment of cancer
    Rotte, Anand
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [12] Combination of CTLA-4 and PD-1 blockers for treatment of cancer
    Anand Rotte
    Journal of Experimental & Clinical Cancer Research, 38
  • [13] Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis
    Mi, Ze
    Zhang, Yunshu
    Feng, Zhichao
    Liu, Jiahao
    Wu, Jianmin
    Tan, Hongpei
    Ma, Xiaoqian
    Liu, Zhenguo
    Rong, Pengfei
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 301 - 309
  • [14] Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer A meta-analysis
    Zhang, Pei-Pei
    Wang, Juan
    Ding, Da-Zhi
    Zhang, Li
    Cheng, Chun
    Chen, Da-Ke
    MEDICINE, 2021, 100 (35) : E27121
  • [15] Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
    Feng, Yuqian
    Jin, Huimin
    Guo, Kaibo
    Xiang, Yuying
    Zhang, Yiting
    Du, Wurong
    Shen, Minhe
    Ruan, Shanming
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [16] A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody
    Song, Qi
    Jiang, Meiling
    Pan, Xinrong
    Zhou, Guanyue
    Zhang, Xiaomeng
    IMMUNOBIOLOGY, 2024, 229 (06)
  • [17] Efficacy of PD-1/PD-L1 inhibitors in advanced gastroesophageal cancer based on characteristics: a meta-analysis
    Liu, Wenjie
    Huo, Gengwei
    Chen, Peng
    IMMUNOTHERAPY, 2023, 15 (10) : 751 - 771
  • [18] Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials
    Wang, Zhenzi
    Liu, Yuan
    Wang, Kedi
    Ma, Liyan
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [19] A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
    Fan, Zhongyuan
    Liang, Ye
    Yang, Xuecheng
    Li, Bin
    Cui, Lili
    Luo, Lei
    Jia, Yuefeng
    Wang, Yonghua
    Niu, Haitao
    ONCOTARGETS AND THERAPY, 2019, 12 : 1791 - 1801
  • [20] The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review
    Chen, Si
    Li, Yuan
    Deng, Chuiwen
    Li, Jing
    Wen, Xiaoting
    Wu, Ziyan
    Hu, Chaojun
    Zhang, Shulan
    Li, Ping
    Zhang, Xuan
    Zhang, Fengchun
    Li, Yongzhe
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 33 - 44
12345